• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

26.33 -0.37 (-1.39%)
Official Closing Price Updated: 7:00 PM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29,318,757
Open 26.60
Bid (Size) 26.37 (400)
Ask (Size) 26.41 (2,000)
Prev. Close 26.70
Today's Range 26.29 - 26.61
52wk Range 21.97 - 28.75
Shares Outstanding 5,606,688,356
Dividend Yield 6.53%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Oversold Stock Ready to Bounce Back and 2 We Find Risky
May 01, 2026
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a co... 
Via StockStory
Topics Artificial Intelligence
News headline image
Pfizer Just Scored a Win That Wall Street Can't Ignore ↗
April 30, 2026
The pharmaceutical giant just extended the lifespan of one of its top drugs. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
+4.6%
+4.6%
1 Month
-7.0%
-7.0%
3 Month
-1.2%
-1.2%
6 Month
+6.8%
+6.8%
1 Year
+8.8%
+8.8%

More News

Read More
News headline image
Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead? ↗
April 30, 2026
Via The Motley Fool
News headline image
Pfizer Says Cancer Therapy Beats Standard Therapy In Late-Stage Blood Cancer Study ↗
April 29, 2026
Via Benzinga
News headline image
Do Wall Street Analysts Like Bristol-Myers Squibb Stock?
April 29, 2026
Via Barchart.com
Topics ETFs
News headline image
Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma
April 29, 2026
From Pfizer Inc.
Via Business Wire
News headline image
2 High-Yielding Dividend Stocks to Buy for Passive Income in April ↗
April 28, 2026
Via The Motley Fool
Topics Economy Intellectual Property
Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session. ↗
April 28, 2026
Via Chartmill
News headline image
Should You Buy, Sell, or Hold Pfizer at $27? ↗
April 28, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Pfizer Reaches Three Settlement Agreements for VYNDAMAX
April 28, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Are Wall Street Analysts Bullish on Pfizer Stock?
April 28, 2026
Via Barchart.com
Topics ETFs Intellectual Property
News headline image
Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal ↗
April 27, 2026
Via The Motley Fool
Topics Stocks
News headline image
Is Bristol Myers Squibb the Best Bargain in Big Pharma? ↗
April 27, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
VCIT vs. IEI Comes Down to What Job Your Bond Sleeve Is Doing ↗
April 25, 2026
Via The Motley Fool
Topics Bonds ETFs
News headline image
Is This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom? ↗
April 25, 2026
Via The Motley Fool
News headline image
Is Pfizer's 6% Dividend Yield Safe? Here's What Investors Need to Know. ↗
April 25, 2026
Via The Motley Fool
Topics Earnings
These S&P500 stocks are the most active in today's session ↗
April 24, 2026
Via Chartmill
News headline image
Unusual Put Activity Is Flagging a Smart Trade Setup in This New Quantum Computing Stock
April 24, 2026
Via Barchart.com
Topics Artificial Intelligence Initial Public Offering
News headline image
Wall Street Says Buy Merck Over Pfizer. The Numbers Tell a More Complicated Story.
April 24, 2026
Via Barchart.com
News headline image
Pfizer Declares Second-Quarter 2026 Dividend
April 22, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Should You Forget Pfizer and Buy This Pharma Stock Instead? ↗
April 22, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Why Merck (MRK) Shares Are Trading Lower Today
April 21, 2026
Via StockStory
Topics Government Intellectual Property
News headline image
A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly ↗
April 21, 2026
Via The Motley Fool
News headline image
This Drug Stock Has Crushed the S&P 500 Over the Last Decade ↗
April 18, 2026
Via The Motley Fool
Topics Intellectual Property Stocks
News headline image
Where Will Pfizer Stock Be in 3 Years? ↗
April 18, 2026
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 26.33
When was Pfizer last traded?
The last trade of Pfizer was at 05/01/26 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 147.62B
How many shares of Pfizer are outstanding?
Pfizer has 148B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap